Investigating how lysosomes communicate with the nucleus to influence aging and lifespan.

TFEB-mediated lysosome-to-nucleus signaling in aging and lifespan regulation

NIH-funded research Baylor College of Medicine · NIH-11051222

This study is looking at how tiny cell structures called lysosomes help control aging and communicate with the cell's nucleus, with the hope of finding new ways to treat age-related diseases and improve how long and healthy we live.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11051222 on NIH RePORTER

What this research studies

This research explores the role of lysosomes in aging and how they communicate with the nucleus to regulate lifespan. By examining a specific signaling pathway involving a transcription factor, the study aims to identify cellular and molecular targets that could lead to treatments for age-related diseases. The approach includes using advanced tools to analyze lysosomal content and signaling mechanisms in aging cells. Patients may benefit from insights that could lead to new therapies aimed at improving healthspan and lifespan.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults experiencing age-related health issues or neurodegenerative conditions.

Not a fit: Patients who are younger and do not have age-related diseases may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance health and longevity in aging populations.

How similar studies have performed: Previous research has shown promising results in extending lifespan through similar cellular signaling pathways, indicating potential for success in this approach.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age associated neurodegenerative diseaseage associated neurodegenerative disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.